NCT06684899View on ClinicalTrials.gov

Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients

Not yet recruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions

GlioblastomaCytokine-Induced Killer Cells

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT06684899 - Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients | Biotech Hunter | Biotech Hunter